Azmi Nabulsi, Chief Operating Officer at Phathom Pharmaceuticals, Inc. (PHAT), sold 28,900 shares at $33.02 ($971K) on 2020-01-04, disclosed to the SEC on 2021-01-05.
Open-market sale of $971k PHAT by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.02 | 4,932 | $163K | 16.8% |
| 2 | $33.02 | 4,932 | $163K | 16.8% |
| 3 | $33.93 | 7,614 | $258K | 26.6% |
| 4 | $33.93 | 7,614 | $258K | 26.6% |
| 5 | $34.57 | 100 | $3K | 0.4% |
| 6 | $33.77 | 1,854 |
| $63K |
| 6.4% |
| 7 | $33.77 | 1,854 | $63K | 6.4% |
| Total | $33.60 avg | 28,900 | $971K | 100% |
| Filing → |
| PHAT | SELL | 2024-07-17 | $256K | — | Filing → |
| PHAT | BUY | 2023-04-11 | $83K | — | Filing → |
| PHAT | BUY | 2022-05-16 | $163K | — | Filing → |